3D Tissue Models Summit

Regulatory and governmental momentum is forcing change, fast:

• The Senate have recently cleared the FDA Modernization Act 3.0
• The FDA have developed a roadmap that’s abandoning animal testing for mAbs
• NIH have closed the door on animal-only grants
• The UK join the plan to phase out animal testing, announced by the Science Minister Lord Vallance
• Meanwhile, your pipelines are chasing novel targets that in vivo models can't predict.

The 11th 3D Tissue Models Summit is where the industry comes to solve this. As the only industry-led forum dedicated to advancing organoids, organ-on-chip, and MPS, you'll connect with scientists from AbbVie, Novartis, Vertex, and many more who are validating these models, securing regulatory buy-in, and making them work at scale. The shift is happening, so make sure your organization is ready.

Featured Products